Toll Free: 1-888-928-9744

Medeia Therapeutics Ltd. - Product Pipeline Review - 2014

Published: Aug, 2014 | Pages: 25 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Medeia Therapeutics Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Medeia Therapeutics Ltd. - Product Pipeline Review - 2014', provides an overview of the Medeia Therapeutics Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Medeia Therapeutics Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Medeia Therapeutics Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Medeia Therapeutics Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Medeia Therapeutics Ltd.'s pipeline products

Reasons to buy

- Evaluate Medeia Therapeutics Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Medeia Therapeutics Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Medeia Therapeutics Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Medeia Therapeutics Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medeia Therapeutics Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Medeia Therapeutics Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Medeia Therapeutics Ltd. Snapshot 4
Medeia Therapeutics Ltd. Overview 4
Key Information 4
Key Facts 4
Medeia Therapeutics Ltd. - Research and Development Overview 5
Key Therapeutic Areas 5
Medeia Therapeutics Ltd. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Medeia Therapeutics Ltd. - Pipeline Products Glance 9
Medeia Therapeutics Ltd. - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
Medeia Therapeutics Ltd. - Drug Profiles 11
MDA-107 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
MDA-308 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
MDA-409 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
MDA-107 Back Up 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Medeia Therapeutics Ltd. - Pipeline Analysis 19
Medeia Therapeutics Ltd. - Pipeline Products by Target 19
Medeia Therapeutics Ltd. - Pipeline Products by Route of Administration 20
Medeia Therapeutics Ltd. - Pipeline Products by Molecule Type 21
Medeia Therapeutics Ltd. - Pipeline Products by Mechanism of Action 22
Medeia Therapeutics Ltd. - Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 25
Disclaimer 25
List of Tables
Medeia Therapeutics Ltd., Key Information 4
Medeia Therapeutics Ltd., Key Facts 4
Medeia Therapeutics Ltd. - Pipeline by Indication, 2014 6
Medeia Therapeutics Ltd. - Pipeline by Stage of Development, 2014 7
Medeia Therapeutics Ltd. - Monotherapy Products in Pipeline, 2014 8
Medeia Therapeutics Ltd. - Preclinical, 2014 9
Medeia Therapeutics Ltd. - Discovery, 2014 10
Medeia Therapeutics Ltd. - Pipeline by Target, 2014 19
Medeia Therapeutics Ltd. - Pipeline by Route of Administration, 2014 20
Medeia Therapeutics Ltd. - Pipeline by Molecule Type, 2014 21
Medeia Therapeutics Ltd. - Pipeline Products by Mechanism of Action, 2014 22 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify